Randomized Controlled Trials as Topic

"Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.

Descriptor ID	D016032
MeSH Number(s)	E05.318.760.250.500.365.500 N05.715.360.775.088.500.387.500 N06.850.520.450.250.250.365.500
Concept/Terms	Randomized Controlled Trials as Topic Randomized Controlled Trials as Topic Clinical Trials, Randomized Clinical Trials, Randomized Trials, Randomized Clinical Controlled Clinical Trials, Randomized Controlled Clinical Trials, Randomized

Below are MeSH descriptors whose meaning is more general than "Randomized Controlled Trials as Topic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Epidemiologic Study Characteristics [E05.318.760]
Clinical Studies as Topic [E05.318.760.250]
Clinical Trials as Topic [E05.318.760.250.500]
Controlled Clinical Trials as Topic [E05.318.760.250.500.365]
Randomized Controlled Trials as Topic [E05.318.760.250.500.365.500]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.775]
Clinical Studies as Topic [N05.715.360.775.088]
Clinical Trials as Topic [N05.715.360.775.088.500]
Controlled Clinical Trials as Topic [N05.715.360.775.088.500.387]
Randomized Controlled Trials as Topic [N05.715.360.775.088.500.387.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Epidemiologic Study Characteristics [N06.850.520.450]
Clinical Studies as Topic [N06.850.520.450.250]
Clinical Trials as Topic [N06.850.520.450.250.250]
Controlled Clinical Trials as Topic [N06.850.520.450.250.250.365]
Randomized Controlled Trials as Topic [N06.850.520.450.250.250.365.500]

Below are MeSH descriptors whose meaning is related to "Randomized Controlled Trials as Topic".

Below are MeSH descriptors whose meaning is more specific than "Randomized Controlled Trials as Topic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Randomized Controlled Trials as Topic" by people in this website by year, and whether "Randomized Controlled Trials as Topic" was a major or minor topic of these publications.

Bar chart showing 66 publications over 21 distinct years, with a maximum of 7 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2005	0	1	1
2006	1	2	3
2007	1	4	5
2008	0	5	5
2009	0	4	4
2010	0	2	2
2011	1	5	6
2012	2	2	4
2013	1	6	7
2014	0	3	3
2015	0	2	2
2016	0	6	6
2017	1	1	2
2018	0	4	4
2019	1	1	2
2020	0	4	4
2021	0	1	1
2022	0	1	1
2023	0	1	1
2024	0	2	2

Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.

Rex N, Ospel JM, Brown SB, McDonough RV, Kashani N, Hill MD, Dippel DWJ, Campbell B, Muir KW, Demchuk AM, Bracard S, Guillemin F, Jovin TG, Mitchell PJ, White P, Majoie CBLM, Saver JL, Goyal M. Endovascular therapy in acute ischemic stroke with poor reperfusion is associated with worse outcomes compared with best medical management: a HERMES substudy. J Neurointerv Surg. 2024 Aug 14; 16(9):878-883.

View in: PubMed
Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. PLoS One. 2024; 19(2):e0297562.

View in: PubMed
Forst DA, Rhee JY, Mesa MM, Podgurski AF, Strander SM, Datta S, Kaslow-Zieve E, Horick NK, Greer JA, El-Jawahri A, Sannes TS, Temel JS, Jacobs J. Study protocol for NeuroCARE: a randomised controlled trial of a psychological intervention for caregivers of patients with primary malignant brain tumours. BMJ Open. 2023 09 07; 13(9):e069410.

View in: PubMed
Santoni M, Rizzo A, Kucharz J, Mollica V, Rosellini M, Marchetti A, Tassinari E, Monteiro FSM, Soares A, Molina-Cerrillo J, Grande E, Battelli N, Massari F. Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis. Cancer Immunol Immunother. 2023 Jun; 72(6):1365-1379.

View in: PubMed
Kenny A, Voldal EC, Xia F, Heagerty PJ, Hughes JP. Analysis of stepped wedge cluster randomized trials in the presence of a time-varying treatment effect. Stat Med. 2022 09 30; 41(22):4311-4339.

View in: PubMed
Ghosh S, Mukhopadhyay S, Majumder P, Wang B. Statistical power and sample size requirements to detect an intervention by time interaction in four-level longitudinal cluster randomized trials. Stat Med. 2022 06 30; 41(14):2542-2556.

View in: PubMed
Pellegrini VD, Eikelboom JW, Evarts CM, Franklin PD, Garvin KL, Goldhaber SZ, Iorio R, Lambourne CA, Magaziner J, Magder L. Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol. BMJ Open. 2022 03 08; 12(3):e060000.

View in: PubMed
Rizzo A, Oderda M, Mollica V, Merler S, Morelli F, Fragomeno B, Taveri E, Sorgentoni G, Santoni M, Massari F. A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents. Anticancer Drugs. 2022 01 01; 33(1):e43-e51.

View in: PubMed
Rizzo A, Mollica V, Santoni M, Rosellini M, Marchetti A, Massari F. Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trials. Future Oncol. 2022 Feb; 18(5):625-634.

View in: PubMed
Stefan MS, Pekow PS, Shea CM, Hughes AM, Hill NS, Steingrub JS, Farmer MJS, Hess DR, Riska KL, Clark TA, Lindenauer PK. Update to the study protocol for an implementation-effectiveness trial comparing two education strategies for improving the uptake of noninvasive ventilation in patients with severe COPD exacerbation. Trials. 2021 Dec 16; 22(1):926.

View in: PubMed

People

Explore

Similar Concepts

Top Journals